Kaivalya Ventures

Kaivalya Ventures (KVI) has designed the first ecosystem for the psychedelic compound 5-MeO-DMT. KVI is the parent company to multiple subsidiaries that focus on different aspects of the molecule, shaping the future of brain health, deep healing, & human advancement. KVI Subsidiaries: Tandava (retreats) was the world's first center focused to the safe and effective use of 5-MeO-DMT in a multi-day retreat setting. It's flagship institute is located in Tepoztlan, Mexico. Tandava also partners for naturalistic research studies and gathers data that supports and informs the other subsidiaries efforts. FIVE (education and research) is focused on education, training, research, and drug discovery/development. The FIVE training program is globally recognized as the gold standard in 5-MeO training. FIVE also offers protocols for brain health and repair via FIVE Neuro. FIVE Discovery (Drug discovery and development) utilizes research from FIVE, informing discovering and creating novel, non-hallucinogenic compounds inspired by 5-MeO-DMT. FIVE Discovery is currently in pre IND phase.